Gentuximab Combined With Paclitaxel Compared With Placebo Combined With Paclitaxel for Gastric Adenocarcinoma.

Clinical trial NCT05919381 · UNKNOWN

Trial details

NCT number: NCT05919381
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Adenocarcinoma of Stomach

Start date: 2022-05-30
Primary completion: 2024-12-01
Enrollment: 752

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.